Michelle Rudek-Renaut

Associate Professor

19992018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Pharmacokinetics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Plasma (human) Chemical Compounds
temozolomide Medicine & Life Sciences
Tandem Mass Spectrometry Medicine & Life Sciences
Liquid chromatography Chemical Compounds
Mass spectrometry Chemical Compounds
Liquid Chromatography Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma

Rubinstein, P. G., Moore, P. C., Rudek-Renaut, M., Henry, D. H., Ramos, J. C., Ratner, L., Reid, E., Sharon, E. & Noy, A., Mar 13 2018, In : AIDS. 32, 5, p. 605-611 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
HIV
Safety
Cytochrome P-450 CYP3A
Ritonavir

Cancer in people living with HIV, version 1.2018: Clinical practice guidelines in oncology

Reid, E., Suneja, G., Ambinder, R. F., Ard, K., Baiocchi, R., Barta, S. K., Carchman, E., Cohen, A., Gupta, N., Johung, K. L., Klopp, A., LaCasce, A. S., Lin, C., Makarova-Rusher, O. V., Mehta, A., Menon, M. P., Morgan, D., Nathwani, N., Noy, A., Palella, F. & 8 othersRatner, L., Rizza, S., Rudek-Renaut, M., Taylor, J., Tomlinson, B., Wang, C. C. J., Dwyer, M. A. & Freedman-Cass, D. A., Aug 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 8, p. 986-1017 32 p.

Research output: Contribution to journalReview article

Practice Guidelines
HIV
Neoplasms
Guidelines
Anus Neoplasms

Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer

Anchoori, R., Jiang, R., Peng, S., Soong, R. S., Algethami, A., Rudek-Renaut, M., Anders, N., Hung, C-F., Chen, X., Lu, X., Kayode, O., Dyba, M., Walters, K. J. & Roden, R. S., Sep 30 2018, In : ACS Omega. 3, 9, p. 11917-11929 13 p.

Research output: Contribution to journalArticle

Proteins
Cells
Tumors
Bearings (structural)
Firefly Luciferases

Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: A randomized, multicenter, placebo-controlled clinical trial

Paller, C., Zhou, X. C., Heath, E. I., Taplin, M. E., Mayer, T., Stein, M. N., Bubley, G. J., Pili, R., Hudson, T., Kakarla, R., Abbas, M. M., Anders, N., Dowling, D., King, S., Bruns, A. B., Wagner, W. D., Drake, C. G., Antonarakis, E., Eisenberger, M., Denmeade, S. R. & 3 othersRudek-Renaut, M., Rosner, G. & Carducci, M. A., Jan 15 2018, In : Clinical Cancer Research. 24, 2, p. 306-315 10 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
Vitis
Prostatic Neoplasms
Placebos
Skin

Population pharmacokinetics and exposure–response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias

on behalf of the ETCTN-6745 study team, Jan 1 2018, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology.

Research output: Contribution to journalArticle

temozolomide
Myeloid Leukemia
Pharmacokinetics
Population
Mucositis